NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

13 hedge funds and large institutions have $1.12M invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$104K
2 -$26.5K
3 -$1K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$729K
2
$104K
3
$91K
4
$71K
5
$57K
6
$54K
7
$4K
8
$2K
9
$2K
10
$1K
11
$1K
12
13